Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Stevanato Group SpAMEX:STVN N 86 PS Ratio is 2.62 as of Sep. 09, 2026, which is 47% below its 10-year median of 4.97. GuruFocus rates MEX:STVN N with a GF Score™ of 86/100 and a GF Value™ of MXN315.25. The stock has 6 warning signs investors should review. Among 803 Medical Devices & Instruments companies, Stevanato Group SpA ranks worse than 61.89% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Stevanato Group SpA's share price is MXN246.00.
Stevanato Group SpA's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was MXN93.80. Hence, Stevanato Group SpA's PS Ratio for today is 2.62.
The historical rank and industry rank for Stevanato Group SpA's PS Ratio or its related term are showing as below:
MEX:STVN N'
s PS Ratio Range Over the Past 10 Years
Min: 2.63 Med: 4.97 Max: 9.37
Current: 3.89
During the past 8 years, Stevanato Group SpA's highest PS Ratio was 9.37. The lowest was 2.63. And the median was 4.97.
MEX:STVN N's PS Ratio is ranked worse than 61.89% of 803
companies
in the Medical Devices & Instruments industry
Industry Median: 2.97
vs MEX:STVN N: 3.89
During the past 12 months, the average Revenue per Share Growth Rate of Stevanato Group SpA was 13.60% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 8.90% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 10.80% per year.
During the past 8 years, Stevanato Group SpA's highest 3-Year average Revenue per Share Growth Rate was 24.90% per year. The lowest was 4.20% per year. And the median was 13.35% per year.
Stevanato Group SpA (MEX:STVN N) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Stevanato Group SpA PS Ratio Related Terms
Stevanato Group SpA PS Ratio Historical Data
* Premium members only.
The historical data trend for Stevanato Group SpA's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:STVN N vs MMED, TFX, MMSI: PS Ratio Comparison
For the Medical Instruments & Supplies subindustry, Stevanato Group SpA's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Stevanato Group SpA PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Stevanato Group SpA's PS Ratio distribution charts can be found below:
* The bar in red indicates where Stevanato Group SpA's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Stevanato Group SpA's Share Price of today is MXN246.00. Stevanato Group SpA's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN93.80.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Stevanato Group SpA (MEX:STVN N) has a PS Ratio of 2.62 as of Sep. 09, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Stevanato Group SpA and its competitors. This is 47% below median its historical median of 4.97. Over the past decade, Stevanato Group SpA's PS Ratio has ranged from 2.63 to 9.37. According to the industry distribution chart, Stevanato Group SpA ranks #497 out of 803 companies in the Medical Devices & Instruments industry, placing it in the top 61.9%.
Is Stevanato Group SpA's PS Ratio too high?
Stevanato Group SpA's current PS Ratio of 2.62 is 47% below median its 10-year median of 4.97. Over the past 10 years, this metric has ranged from a low of 2.63 to a high of 9.37. The Medical Devices & Instruments industry median PS Ratio is 2.97. Stevanato Group SpA's value of 2.62 is 11.8% below this industry median. Based on the distribution chart, Stevanato Group SpA ranks #497 out of 803 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Stevanato Group SpA has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does Stevanato Group SpA's PS Ratio compare to MMED and TFX?
According to the Medical Devices & Instruments industry distribution chart, Stevanato Group SpA ranks #497 out of 803 companies for PS Ratio. This places Stevanato Group SpA in the lower half of its industry. The industry median PS Ratio is 2.97. Stevanato Group SpA's value of 2.62 is 11.8% below this benchmark. Historically, Stevanato Group SpA's own PS Ratio has ranged from 2.63 to 9.37 over the past decade. While the company's 10-year median is 4.97 vs. the industry median of 2.97, Stevanato Group SpA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.97, based on 803 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Stevanato Group SpA's current PS Ratio of 2.62 is 11.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Stevanato Group SpA and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Stevanato Group SpA's current PS Ratio is 2.62, which is 47% below median its own 10-year median of 4.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stevanato Group SpA stock overvalued right now?
Stevanato Group SpA (MEX:STVN N) has a current PS Ratio of 2.62. The stock's GF Value™ is MXN315.25, compared to a current price of MXN246.00 — trading 22% below its estimated fair value. The current PS Ratio is 2.62, which is 47% below median its 10-year median of 4.97 and 11.8% below the Medical Devices & Instruments industry median of 2.97. Stevanato Group SpA's overall GF Score™ is 86/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Stevanato Group SpA (MEX:STVN N), the current PS Ratio is 2.62 as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Stevanato Group SpA (MEX:STVN N) Overvalued in 2026?
Based on GuruFocus' analysis, Stevanato Group SpA stock appears to be undervalued.
The current stock price of MXN246.00 is trading 22% below its estimated GF Value™ of MXN315.25.
Key valuation signals for MEX:STVN N:
PS Ratio: 2.62 (47% below median its 10-year median of 4.97)
GF Value™: MXN315.25 vs. price of MXN246.00 (22% below fair value)
Industry Position: 11.8% below the Medical Devices & Instruments median (#497 of 803)
No single metric tells the full story. See the MEX:STVN N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.
86GF Score
Get the complete analysis for MEX:STVN N
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:STVN N has been successfully added to your 
